A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...
Since GLP-1s hit the mainstream roughly two years ago, people taking the weight-loss drugs noticed their cravings for food disappear. For some, that extended to alcohol, too. Now, the growing buzz ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
but also for tobacco and alcohol. Scientists are studying these drugs in smokers, people with opioid addiction and cocaine users. “This is such promising data. And we need more of it,” said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results